---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-25-000034"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T05:56:49.821362+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# PetMed Express prelim Q4 sales $51-53M vs $66.5M; net loss widens to $10M; delays 10-K

## Summary
- Q4 net sales estimated $51.1-53.1M (down ~21% YoY); net loss $9.9-10.4M vs $5.0M prior year.
- FY2025 net sales $231.6-233.6M (down ~17% YoY); FY net loss $4.5-5.0M vs $7.5M prior year.
- FY net loss includes $8.7M non-cash benefit from executive departure and $6.4M deferred tax asset valuation allowance.
- Cash position $54.7M with no debt as of March 31, 2025.
- Company filed Form 12b-25; expects to file annual 10-K by July 1, 2025.

## SEC filing metadata
- accession: 0001040130-25-000034
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/0001040130-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013025000034/pets-20250616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-25-000034
- JSON: https://secwatch.observer/filing/0001040130-25-000034.json
- Plain text: https://secwatch.observer/filing/0001040130-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.